These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9157573)

  • 21. The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors.
    Tizzano EF; Soria JM; Coll I; Guzmán B; Cornet M; Altisent C; Martorell M; Domenech M; del Río E; Fontcuberta J; Baiget M
    Haematologica; 2002 Mar; 87(3):279-85. PubMed ID: 11869940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of factor VIII intron 1 inversion in severe haemophilia A].
    Liang Y; Yan ZY; Yan M; Hua BL; Xiao B; Zhao YQ; Liu JZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):323-5. PubMed ID: 19504449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of inhibitors in haemophilia A.
    Kreuz W; Escuriola-Ettingshausen C; Martinez-Saguer I; Güngör T; Kornhuber B
    Vox Sang; 1996; 70 Suppl 1():2-8. PubMed ID: 8869461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genotyping of hemophilia A in Saudi Arabia: report of 2 novel mutations.
    Owaidah TM; Alkhail HA; Zahrani HA; Musa AA; Saleh MA; Riash MA; Alodaib A; Abu Amero K
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):415-8. PubMed ID: 19448530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.
    Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W;
    Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of factor VIII inhibitors.
    Hay CR
    Haemophilia; 2006 Dec; 12 Suppl 6():23-8; discussion 28-9. PubMed ID: 17123390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular genetics of hemophilia A].
    De Brasi CD; Slavutsky IR; Larripa IB
    Medicina (B Aires); 1996; 56(5 Pt 1):509-17. PubMed ID: 9239887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype.
    Margaglione M; Castaman G; Morfini M; Rocino A; Santagostino E; Tagariello G; Tagliaferri AR; Zanon E; Bicocchi MP; Castaldo G; Peyvandi F; Santacroce R; Torricelli F; Grandone E; Mannucci PM;
    Haematologica; 2008 May; 93(5):722-8. PubMed ID: 18387975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors in haemophilia: pathophysiology.
    Saint-Remy JM; Lacroix-Desmazes S; Oldenburg J
    Haemophilia; 2004 Oct; 10 Suppl 4():146-51. PubMed ID: 15479388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A.
    Andrikovics H; Klein I; Bors A; Nemes L; Marosi A; Váradi A; Tordai A
    Haematologica; 2003 Jul; 88(7):778-84. PubMed ID: 12857556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epistatic effects occurring among susceptibility and protective MHC genes in IgA deficiency.
    Martínez A; Gual L; Fernández-Arquero M; Nogales A; Ferreira A; Garcia-Rodriguez MC; Fontan G; de la Concha Ed EG
    Genes Immun; 2003 Jun; 4(4):316-20. PubMed ID: 12761569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibody.
    Frommel D; Allain JP; Saint-Paul E; Bosser C; Noël B; Mannucci PM; Pannicucci F; Blombäck M; Prou-Wartelle O; Muller JY
    Thromb Haemost; 1981 Dec; 46(4):687-9. PubMed ID: 6800049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
    Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
    Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India.
    Jayandharan G; Shaji RV; George B; Chandy M; Srivastava A
    Haemophilia; 2004 Sep; 10(5):553-9. PubMed ID: 15357783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic control by the HLA region of the immune response to factor VIII in hemophilic patients].
    Nuñez-Roldan A; Arnaiz-Villena A; Nuñez-Ollero G
    C R Seances Acad Sci D; 1979 Jun; 288(23):1719-20. PubMed ID: 114335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic risk factors for inhibitors to factors VIII and IX.
    Oldenburg J; Pavlova A
    Haemophilia; 2006 Dec; 12 Suppl 6():15-22. PubMed ID: 17123389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor.
    Sugihara T; Takahashi I; Kojima T; Okamoto Y; Yamamoto K; Kamiya T; Matsushita T; Saito H
    Nagoya J Med Sci; 2000 May; 63(1-2):25-39. PubMed ID: 10911718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors in young boys with haemophilia.
    Lusher JM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-inversion factor VIII mutations in 80 hemophilia A families including 24 with alloimmune responses.
    Liu ML; Nakaya S; Thompson AR
    Thromb Haemost; 2002 Feb; 87(2):273-6. PubMed ID: 11858487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.